Neurological manifestations of syphilis-HIV coinfection in South Africa.

Clinical presentation HIV infection Neurosyphilis Penicillin South Africa

Journal

Journal of the neurological sciences
ISSN: 1878-5883
Titre abrégé: J Neurol Sci
Pays: Netherlands
ID NLM: 0375403

Informations de publication

Date de publication:
15 Dec 2023
Historique:
received: 06 07 2023
revised: 27 10 2023
accepted: 12 11 2023
pubmed: 19 11 2023
medline: 19 11 2023
entrez: 18 11 2023
Statut: ppublish

Résumé

Syphilis and HIV coinfection is highly prevalent in South Africa, and both can cause neurological complications. We describe the clinical presentation and outcome of neurosyphilis in patients with and without HIV coinfection diagnosed at a tertiary facility, Groote Schuur Hospital (GSH), in South Africa. We retrospectively analyzed folders of adults with positive cerebrospinal fluid (CSF) fluorescent treponemal antibody absorption test in 2018 and 2019, with follow-up data collected until 2022. HIV-coinfection was identified in 35% of the 69 included patients. Patients with HIV-coinfection were more likely to be female (58% vs 25% female, p < 0.01), and present earlier (median age = 31 years vs. 40 years, p < 0.001). Neuropsychiatric manifestations (confusion, dementia, psychosis), and strokes were the commonest clinical presentations in both groups. Those with HIV-coinfection were significantly less likely to be diagnosed with neurosyphilis by the treating clinician (71% vs. 91%, p < 0.05), as were those with a negative CSF Venereal Disease Research Laboratory (74% vs. 94%, p < 0.05). Accurate diagnosis of neurosyphilis was associated with an increased 12-month survival (alive: N = 36 [63%]) relative to those who did not receive an accurate diagnosis (alive: N = 2 [17%], p < 0.05). Those who were optimally treated with antibiotics had significantly higher 12-month survival (alive: N = 33, 63%) compared to those with suboptimal treatment (alive: N = 5, 29%), p < 0.01. Neurosyphilis presented similarly in those with and without HIV-coinfection. Accurate identification and optimal antibiotic treatment of neurosyphilis, particularly in CSF VDRL negative patients and those with HIV-coinfection, is necessary to improve patient survival.

Identifiants

pubmed: 37979416
pii: S0022-510X(23)02259-1
doi: 10.1016/j.jns.2023.122798
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

122798

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest No conflicts of interest.

Auteurs

E F Shorer (EF)

Division of Neurology, Groote Schuur Hospital, University of Cape Town, South Africa; Department of Neurology, Johns Hopkins Hospital, Baltimore, MD, USA. Electronic address: dreranshorer@gmail.com.

C Z Zauchenberger (CZ)

Division of Neurology, Groote Schuur Hospital, University of Cape Town, South Africa.

S Govender (S)

Division of Neurology, Groote Schuur Hospital, University of Cape Town, South Africa.

G E Shorer (GE)

Division of Neurology, Groote Schuur Hospital, University of Cape Town, South Africa.

A A Geragotellis (AA)

Division of Neurology, Groote Schuur Hospital, University of Cape Town, South Africa.

C M Centner (CM)

Division of Medical Microbiology, University of Cape Town; National Health Laboratory Service, Groote Schuur Hospital, Cape Town, South Africa.

S Marais (S)

Division of Neurology, Groote Schuur Hospital, University of Cape Town, South Africa; Neuroscience Institute, UCT, South Africa.

Classifications MeSH